The biotechnology market size was estimated to reach US$ 471,336.40 million by 2025 from US$ 218,012.10 million in 2017; it is estimated to grow at a CAGR of 10.5% during 2017-2025.
Market Insights and Analyst View:
Biotechnology is used in variety of applications that includes industrial/bio processing, bioinformatics, food & agriculture, health, natural resources & environment, and others. In addition, the modern biotechnology enables to provide outstanding innovations for products and technologies against the unbearable and rare diseases it also reduces environmental footprint, feed the hungry. Furthermore, it utilizes less and cleaner energy for safer, cleaner and more efficient industrial manufacturing processes. Factors such as declining prices of genome sequencing, increasing innovative technologies bolstering the Biotechnology market growth. Additionally, increasing number of initiatives by private and government bodies are also driving the Biotechnology market growth. Moreover, rising Future conferences and workshops is expected to be the Biotechnology Market Trend in the future.
Growth Drivers and Challenges:
The informatics experts and biologists using newer sequencing technologies by aiming at making better genomes. The improving software technologies for piecing DNA together and increasing novel techniques for locating sequences on chromosomes have risen in the recent years. To support the adoption of newer technologies with improved tools and techniques, several programs established. For instance, in 1989, the Genome Sequencing Program of the National Human Genome Research Institute (NHGRI) was established to address current scientific opportunities for Genomics.
The Genome Technology program is also supports to develop novel technologies with improved method and instruments that allow low-cost rapid determination of DNA sequence, functional genomics experiments and SNP genotyping. The Genome Technology program also supports the technology transfer from developers to the users and helps in promoting collaborative multidisciplinary programs that closely incorporate at industrial and academic laboratories. Moreover, many industry players have come up with innovative NGS technology in last few years. For instance, Pacific Biosciences with Sequel, and Oxford Nanopore with PromethION. Additionally, three advances NSG systems that dominate the market includes Roche GS FLX (454), Illumina HiSeq 2000 (Solexa) and AB SOLiD (Agencourt). Advancement in genome sequencing has made the sequencing easy and accurate.
Thus, due to the technological advancements the Biotechnology market is expected to grow at rapid pace.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Biotechnology Market: Strategic Insights
Market Size Value in US$ 218,012.10 Million in 2017 Market Size Value by US$ 471,336.40 Million by 2025 Growth rate CAGR of 10.5% from 2017 to 2025 Forecast Period 2017-2025 Base Year 2017
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Biotechnology Market: Strategic Insights
| Market Size Value in | US$ 218,012.10 Million in 2017 |
| Market Size Value by | US$ 471,336.40 Million by 2025 |
| Growth rate | CAGR of 10.5% from 2017 to 2025 |
| Forecast Period | 2017-2025 |
| Base Year | 2017 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Biotechnology Market Segmentation and Scope:
The “Global Biotechnology Market” is segmented based on technology, application, and geography. The Biotechnology market by technology is segmented into DNA sequencing, fermentation, cell based assay, nanobiotechnology, chromatography, PCR technology, tissue engineering and regeneration, other technologies. Based on application, the Biotechnology market is segmented into industrial processing, bioinformatics, food & agriculture, health, natural resources & environment, other applications. The Biotechnology market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Russia, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Segmental Analysis:
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Based on product, the Biotechnology market is segmented into DNA sequencing, fermentation, cell-based assay, nanobiotechnology, chromatography, PCR technology, tissue engineering and regeneration, other technologies. The DNA sequencing segment held the largest share of the market in 2017 and the same segment is likely to grow at a highest rate during the forecast period. DNA sequencing is the technique which is used to determine the specific order of the nucleotide bases that forms the strand of DNA. Currently it is an essential technique for the many of the basic and applied research studies and its applications. The technique of DNA sequencing was used in the human genome project which took thirteen years for its completion and helped to understand the cause of the genetic changes in the genetic diseases. The technique also helps to target the specific gene that can be used to design the drugs for the specific genetic disease. In addition, the DNA sequencing is used for the genetic testing for the paternity and other family relationship. Moreover, the DNA sequencing is used for the identifying the crime suspects and victims through the forensic studies. Furthermore, the techniques also have important role for analyzing the bacteria, and other microorganisms that are responsible for polluting air, water and food. DNA sequencing is majorly used to identify and study variations in different group of animals and plants and their migratory patterns for determining the rare breed for seed or livestock. Many companies like Thermo Fisher Scientific Inc., Merck KGaA, Illumina, Inc. and various other start-up companies offers various kits and reagents for the DNA sequencing technique. Thus, the advantages offered by DNA sequencing and their use in the above-mentioned applications are expected to robust the growth of the segment in the forecast period.
Based on application, the Biotechnology market is segmented into industrial processing, bioinformatics, food & agriculture, health, natural resources & environment, other applications. The industrial processing segment held the largest share of the market in 2017; whereas the bioinformatics segment is likely to grow at a higher rate during the forecast period. The industrial processing or the bioprocessing market is among the most promising field of the biotechnology that is impacting the healthcare, and agriculture biotechnology market significantly and also, it’s a new approach for the prevention of pollution and conserving the resources. The industrial processing or the bioprocessing market offers business that offers lower costs and create new market by disturbing the environment. Most of the lab studies in the biotechnology are taken out for the commercial applications. The applications are used for the drug discovery and the drug development. The developments for the therapeutics human proteins are done through the recombinant methods. For instance, recombinant human insulin is the first recombinant medicine produced and was marketed by Genetech in 1982. The rise in the prevalence of the diabetes have gained a huge profit for the recombinant insulin and have significant biotechnology market growth in future. Moreover, the application of industrial processing includes the production of enzymes and micro-organisms to make bio-based products in sectors such as chemicals, food ingredients, detergents, paper, textiles, beverages, fabrics, plastics, personal care, biofuels and more.
There is various process involved in the drug development process under the industrial processing. The steps such as discovery and development is the first step which is followed by the preclinical research, clinical research, FDA review and lastly the FDA post market safety monitoring. Many of the biopharmaceutical companies are involved in the process of drug development. The major product for the drug discovery and development is the protein which is offered by the various biotechnology companies. Many of the companies are involved in the expansion of the biopharmaceutical drugs that can be used to treat diseases like hepatitis, cancer and heart disease. The prevalence of the diseases is likely to enforce the biotechnology companies to produce more of the raw material required for the development of drug and thus, the companies are engaged in conducting the lab studies more aggressively. Therefore, considering the factors the application of the biotechnology for the industrial processing are likely to grow significantly in the coming near future.
Biotechnology Market, by Product– 2017 and 2025
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Regional Analysis:
Based on geography, the Biotechnology market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. In 2017, North America held the largest share of the global Biotechnology market, and Asia Pacific is estimated to register the highest CAGR during the forecast period. North America is largest market for biotechnology with the US holding the largest market share followed by Canada. The growth in North America is characterized by increase in the demand of innovative products from biopharmaceutical and biotechnology companies, presence of key market players and extensive R&D conducted by various academic and research institutes. Moreover, increasing focus on advanced method incorporation in healthcare, government and private initiatives for promotion of precision medicine and massive funds from government and private bodies for genomic research is further expected stimulate the growth and contribute to exceptional revenue generation for the biotechnology market in North America. The medical and agricultural biotechnology has undergone revolutions as a result of various development programs, business strategies that helps to produce, discover or alter various biomolecules and organisms through bioengineering approaches.
Further, the US biotechnology industry remains a global benchmark and is considered to be one of the fastest growing and successful market which is likely to maintain its position during the foreseeable future. Advances in science and technology as well as growing understanding of the underlying mechanisms are supporting development of new treatments for patients using biotechnological approaches in the US. The bionic eye, 3D printed organs, bioelectric cancer detection are few some of the major advances encountered by the country within the last few years in the field of biotechnology. Additionally, according to Journal of American Medical Association, the healthcare spending in the US is twice the rate of other high-income countries in the world.
The Biotech Startup Revolution has also assisted to promote the new ventures holding promising and innovative ideas in the region and supported in maximizing the revenue generation and thus the global economic position of North America in the global biotechnology market.
Industry Developments and Future Opportunities:
Various initiatives taken by key players operating in the global Biotechnology market are listed below:
- In April 2022, CytoTronics raised US$9.25M in initial seed funding, led by Anzu Partners, with the association of Milad Alucozai (BoxOne Ventures) and institutional investors. The company will use this seed funding to promote its innovative platform that utilizes computer chip technology to conduct electrical and electrochemical cell-based assays.
- In June 2021, Element Raised US$276 Million in Series C Financing for DNA Sequencing Platform. The sequencing platform is designed to lower the cost of genomic applications while materially enhancing quality by retooling a DNA sequencing system’s fundamental element, including sequencing chemistry, surface chemistry, detection, and data analysis for research and diagnostic users.
- In February 2021, Selvita launched its new cell-based phenotypic assay platform for drug discovery. The Platform will be used to test new compounds with therapeutic potential in multiple areas, including neuroinflammatory, fibrotic diseases, and others, addressing specific constraints of existing therapeutic methods. The Platform will enable Selvita to complement its integrated drug discovery portfolio of services with a novel, powerful method to discover and develop new medicines quickly and effectively.
- In December 2021, Thermo Fisher Scientific Inc. announced that it had completed its acquisition of PPD, Inc., a leading global provider of clinical research services to the biopharma and biotech industry, for US$17.4 billion.
Covid-19 Impact:
The COVID-19 pandemic has positively impacted the biotechnology market. Companies are developing new treatment options for battling the COVID-19 outbreak. For instance, in December 2020, Thermo Fisher Scientific announced the CE-marking of its TaqPath COVID-19, Flu A/B, respiratory syncytial virus (RSV) Combo Kit for the in vitro diagnosis of SARS-CoV-2, RSV A/B infections, and influenza A/B.
There is an increase in advancements and opportunities for drug development and manufacturing of vaccines for the COVID-19 infection. For instance, according to the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), over 11 billion doses of the COVID-19 vaccine were produced across the globe, resulting in the largest immunization program globally. Furthermore, the boom of mRNA vaccines and accelerated approval processes have led to an upsurge in vaccine-related revenues, as evident by a united revenue generation of about USD 31 billion in 2021 from Pfizer/BioNTech and Johnson & Johnson Moderna vaccines.
Competitive Landscape and Key Companies:
Some of the prominent players operating in the global Biotechnology market include Thermo Fisher Scientific Inc., Merck KGaA, F. Hoffmann-La Roche Ltd, PerkinElmer Inc., Danaher, QIAGEN, Agilent Technologies, BD, Bio-Rad Laboratories, Inc. and Illumina, Inc. These companies focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which provides them to serve a large set of customers and subsequently increases their market share.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Frequently Asked Questions
The biotechnology in healthcare market is projected to reach US$ 471,336.4 million by 2027; it is expected to grow at a CAGR of 10.5%
The forecast period of biotechnology in healthcare market is 2017 - 2025.
Key factors that are driving the growth of this market are the declining prices of genome sequencing, increasing innovative technologies, increasing number of initiatives by private and government bodies.
Factors such as risks associated with genetic data and systemic risks of genetically modified crops are likely to restrain the market growth to a certain extent.
As per Technology based insights, the nanotechnology segment is fastest growing segment and is accounted to grow at the CAGR of 13.2%.
The DNA sequencing is the largest segment among the technology segment in the biotechnology market in 2017 and is also anticipated to hold the largest market in the year 2025.
The List of Companies
1. Thermo Fisher Scientific Inc.
2. Merck KGaA
3. PerkinElmer, Inc.
4. Agilent Technologies, Inc.
5. F. Hoffmann-La Roche Ltd.
6. Danaher
7. QIAGEN
8. BD
9. Bio-Rad Laboratories, Inc.
10. Illumina, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Biotechnology Market
Sep 2018
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2018
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2018
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2018
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2018
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2018
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2018
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Sep 2018